
17 November 2026
Johnson Winter Slattery is pleased to announce that it is advising Gedeon Richter Plc. (Richter) on its proposed acquisition of Mayne Pharma Group Limited (Mayne Pharma) by way of scheme of arrangement.
The proposed transaction involves Richter acquiring all of the shares in Mayne Pharma, via an all-cash offer valuing Mayne Pharma’s equity at $604 million, and representing a 99.4% premium to the last traded price of Mayne Pharma shares.
Mayne Pharma is an ASX-listed specialty pharmaceutical company, focused on commercialising novel pharmaceuticals. Mayne Pharma is a leader in women’s health and dermatology in the United States.
Richter is a specialty pharmaceutical company, founded in Hungary 125 years ago, with operations in around 50 countries globally. With expertise in women’s health, neuropsychiatry, biotechnology and general medicines, Richter’s activities range from original research and development, through manufacturing, to trade and marketing.
If approved by Mayne Pharma shareholders and the court, the transaction will further enhance Richter’s place as one of the leading players in women’s health in Europe and beyond. Led by Corporate Partner James Rozsa, with a core deal team including Scott Cummins (Special Counsel), Byron Koster (Partner) and Oscar Liu (Senior Associate), the Johnson Winter Slattery team advised on all Australian legal aspects of the transaction, working alongside Hogan Lovells Cadwalader on US legal matters.
Rozsa said, “We are delighted to be working with Gedeon Richter on this significant transaction; and are glad that Mayne Pharma shareholders will get another opportunity to realise a strong value for their investment after the disappointment associated with the Cosette bid last year. We look forward to continuing to work with both organisations to drive the scheme through to implementation.”
About Johnson Winter Slattery
JWS is a leading Australian law firm of more than 500 people, including 85+ partners, across Sydney, Melbourne, Canberra, Perth, Brisbane, Adelaide and New York. The firm is engaged by major corporates and investment funds on their most complex transactions, disputes and regulatory matters.
Sydney | Melbourne | Canberra | Perth | Brisbane | Adelaide | New York
Key legal contact
James Rozsa
Partner, Corporate
T: +61 2 8274 9541 | M: +61 419 012 294
E: james.rozsa@jws.com.au
Media contact
Caroline Raven
Head of Communications
T: +61 2 8247 9604 | M: +61 407 957 779
E: caroline.raven@jws.com.au


